No substrate information.
Transporter |
Synonyms |
Inhibitor |
IC50 (μM) |
Ki (μM) |
Substrate used |
Cell System |
Reference |
ABCC1 |
MRP1 |
Indomethacin |
7 |
|
2',7'-bis-(3-carboxy-propyl)-5-(and-6)-carboxyfluorescein (BCPCF) |
human erythrocytes |
Lania-Pietrzak, 2005 |
SLC22A8 |
OAT3 |
Indomethacin |
0.11 |
|
6-carboxyfluorescein |
HEK293-OAT3 |
Zou, 2021 |
SLC22A6 |
OAT1 |
Indomethacin |
4.35 |
|
6-carboxyfluorescein |
HEK293-OAT1 |
Zou, 2021 |
SLC22A6 |
OAT1 |
Indomethacin |
3 |
|
Adefovir |
CHO-OAT1 |
Mulato, 2000 |
ABCC2 |
MRP2, cMOAT |
Indomethacin |
235 |
|
Calcein AM |
MRP2-expressing MDCK-II cells |
Leyers, 2008 |
SLCO2B1 |
OATP2B1, OATP-B |
Indomethacin |
16.3 |
|
Dibromofluorescein |
HEK293-OATP2B1 |
Unger, 2020 |
SLCO1B1 |
OATP1B1, OATP-C, OATP2, LST-1 |
Indomethacin |
12 |
11 |
Estradiol-17beta-glucuronide |
HEK-OATP1B1 |
Karlgren, 2012 |
ABCC3 |
MRP3 |
Indomethacin |
66 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
ABCC4 |
MRP4 |
Indomethacin |
5.8 |
|
Estradiol-17beta-glucuronide |
Sf9 cell membrane vesicles |
Morgan, 2013 |
SLC22A11 |
OAT4 |
Indomethacin |
10.1 |
|
Estrone sulfate |
S2-OAT4 |
Khamdang, 2002 |
SLC22A8 |
OAT3 |
Indomethacin |
0.61 |
|
Estrone sulfate |
S2-OAT3 |
Khamdang, 2002 |
OSTalpha |
OSTA |
Indomethacin |
~200 |
|
Estrone sulfate |
OSTalpha-OSTbeta expressing oocytes |
Seward, 2003 |
OSTbeta |
OSTB |
Indomethacin |
~200 |
|
Estrone sulfate |
OSTalpha-OSTbeta expressing oocytes |
Seward, 2003 |
ABCC2 |
MRP2, cMOAT |
Indomethacin |
0.06 |
|
Methotrexate |
MRP2-expressing HEK293 vesicles |
El-Sheikh, 2007 |
ABCC4 |
MRP4 |
Indomethacin |
6.1 |
|
Methotrexate |
MRP4-expressing HEK293 vesicles |
El-Sheikh, 2007 |
ABCC6 |
MRP6 |
Indomethacin |
ND |
|
N-ethylmaleimide S-glutathione |
MRP6-expressing Sf9 vesicles |
Ilias, 2002 |
SLC22A6 |
OAT1 |
Indomethacin |
3.83 |
|
Para-aminohippurate |
S2-OAT1 |
Khamdang, 2002 |
SLC22A6 |
OAT1 |
Indomethacin |
1.91 |
|
Para-Aminosalicylic acid (PAS) |
HEK293-OAT1 |
Parvez, 2017 |
SLC22A8 |
OAT3 |
Indomethacin |
2.18 |
|
Para-Aminosalicylic acid (PAS) |
HEK293-OAT3 |
Parvez, 2017 |
SLC22A7 |
OAT2 |
Indomethacin |
64.1 |
|
Prostaglandin F2-alpha |
S2-OAT2 |
Khamdang, 2002 |
ABCB11 |
BSEP |
Indomethacin |
42 |
|
Taurocholate |
Sf9 cell membrane vesicles |
Morgan, 2013 |
No drug-drug interaction information.